Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Kasper

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Deutsches Arzteblatt International|February 26, 2025
The Pharmacologic Inhibition of KRAS Mutants as a Treatment for Cancer: Therapeutic Principles and Clinical ResultsStefan Kasper, Martin Sebastian
European Journal of Cancer (Oxford, England : 1990)|February 6, 2014
Targeted therapies in gastroesophageal cancerStefan Kasper, Martin Schuler
Innere Medizin (Heidelberg, Germany)|October 19, 2022
[New treatment option for locally advanced dMMR/MSI<sup>high</sup> rectal cancer]Stefan Kasper-Virchow, Sirka Nitschmann
Der Radiologe|February 14, 2020
[What does the nonradiologist expect from the radiologist?]Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
Seminars in Nuclear Medicine|August 10, 2020
Molecular Imaging and Therapy of Colorectal and Anal CancerPatrick Sandach, Stefan Kasper-Virchow, Christoph Rischpler, et al.
Endoscopy International Open|December 3, 2020
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patientsAlexander Dechêne, Stefan Kasper, Hans Olivecrona, et al.
HNO|January 13, 2019
[Immuno-oncology of head and neck tumors]Stefan Kasper, Timon Hussain, Isabel Virchow, et al.
International Journal of Medical Informatics|May 27, 2019
Natural language processing of German clinical colorectal cancer notes for guideline-based treatment evaluationMatthias Becker, Stefan Kasper, Britta Böckmann, et al.
Transfusion|June 22, 2007
Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathyStefan Kasper, Markus F Neurath, Christoph Huber, et al.
Journal of Cancer Research and Clinical Oncology|December 29, 2011
Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancerBoyka Markova, Patricia S Hähnel, Stefan Kasper, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Deutsches Arzteblatt International|February 26, 2025
The Pharmacologic Inhibition of KRAS Mutants as a Treatment for Cancer: Therapeutic Principles and Clinical ResultsStefan Kasper, Martin Sebastian
European Journal of Cancer (Oxford, England : 1990)|February 6, 2014
Targeted therapies in gastroesophageal cancerStefan Kasper, Martin Schuler
Innere Medizin (Heidelberg, Germany)|October 19, 2022
[New treatment option for locally advanced dMMR/MSI<sup>high</sup> rectal cancer]Stefan Kasper-Virchow, Sirka Nitschmann
Der Radiologe|February 14, 2020
[What does the nonradiologist expect from the radiologist?]Stefan Kasper, Isabel Virchow, Boris Hadaschik, et al.
Seminars in Nuclear Medicine|August 10, 2020
Molecular Imaging and Therapy of Colorectal and Anal CancerPatrick Sandach, Stefan Kasper-Virchow, Christoph Rischpler, et al.
Endoscopy International Open|December 3, 2020
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patientsAlexander Dechêne, Stefan Kasper, Hans Olivecrona, et al.
HNO|January 13, 2019
[Immuno-oncology of head and neck tumors]Stefan Kasper, Timon Hussain, Isabel Virchow, et al.
International Journal of Medical Informatics|May 27, 2019
Natural language processing of German clinical colorectal cancer notes for guideline-based treatment evaluationMatthias Becker, Stefan Kasper, Britta Böckmann, et al.
Transfusion|June 22, 2007
Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathyStefan Kasper, Markus F Neurath, Christoph Huber, et al.
Journal of Cancer Research and Clinical Oncology|December 29, 2011
Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancerBoyka Markova, Patricia S Hähnel, Stefan Kasper, et al.
Pageof 12